iFocus Health

What iFocus Health does

iFocus Health was a privately held digital health company founded in 2021 and headquartered in San Francisco that built AI-driven technology to objectively measure ADHD treatment efficacy. Its core product, iFocus Measure, used only a patient's existing laptop webcam to capture eye-movement data while the patient performed natural reading tasks; a proprietary AI algorithm then processed that data into an iFocus score and a comprehensive report. The product targeted three user groups: adult and pediatric ADHD patients seeking objective evidence of medication effectiveness, parents monitoring their children's treatment progress, and clinicians — including psychiatrists, neurologists, and PMHNPs — needing quantifiable biomarkers to supplement subjective patient feedback.

The platform combined computer-vision-based eye tracking with predictive analytics and was supported by peer-reviewed validation in the Journal of Attention Disorders and Juniper Publishing case reports. Distribution was self-serve via web with a dedicated clinician portal at ifocushealth.co, and the product was free during its public period with no disclosed pricing; structurally the revenue model was oriented toward a recurring SaaS subscription. The company was lean (1–10 employees) and had raised at least $300,000 in disclosed funding by mid-2023. In September 2025, iFocus Health's technology was acquired by HarmonEyes, a company described as a leader in eye tracking and AI, and the original iFocus platform was discontinued after September 1, 2025, with HarmonEyes committed to developing the next version.

Name

iFocus Health

Legal name

iFocus Health Inc.

Website

https://ifocustest.com

Company type

Private

Founded year

2021

Operating status

Acquired

Headcount range

1–10 employees

Short description

iFocus Health was a digital health company using webcam-based eye tracking and proprietary AI to objectively measure ADHD treatment efficacy for patients, parents, and clinicians. Its technology was acquired by HarmonEyes in September 2025, with the original platform discontinued thereafter.

Ownership category

akta.pro rank

Product category

Digital Health Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Behavioral Health & Substance Use Remote Monitoring (HLACAFAD)

akta.pro secondary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

Keywords

• ADHD treatment measurement
• Digital health platform
• Eye-tracking technology
• Behavioral health assessment
• AI-driven diagnostics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscription: Digital health platform providing ADHD treatment measurement services. Patients and clinicians use the platform to track treatment efficacy. The platform was available through September 1st, 2025 when the current iFocus platform was discontinued after acquisition by HarmonEyes.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

iFocus Health operates a digital health platform that objectively measures ADHD treatment efficacy using only a patient's webcam. Patients read naturally while the platform captures eye-movement data, which a proprietary AI algorithm processes to generate an iFocus score and comprehensive report. The report combines objective eye-tracking metrics with self-reported assessments (sleep, mood, appetite, medication side effects) to enable clinicians to make data-driven treatment decisions.

Product overview

iFocus Health offers iFocus Measure — a unified platform for objective ADHD treatment measurement. The core system uses a Chrome-extension-enabled webcam to capture eye-tracking data during reading sessions; a proprietary AI algorithm processes this data to generate iFocus scores and comprehensive reports. The Navigator sub-product provides role-based entry points (patients, parents, clinicians) into the platform. Patients perform 4 unmedicated and 2 medicated reading sessions to produce an iFocus score, which clinicians use alongside self-reported assessments to make data-driven treatment decisions. The company's technology was acquired by HarmonEyes in 2025, with a new platform version planned.

Differentiator

Problem solved

Functional benefit

Products and services

• iFocus Measure A digital health platform that measures ADHD treatment efficacy using only a webcam. Patients read naturally while the webcam captures eye-movement data; a proprietary AI algorithm processes the data and generates an iFocus score and comprehensive report for clinicians to make data-driven treatment decisions.
• Navigator A portal that directs users to relevant information based on their role (clinician, provider, or patient), providing role-specific guidance and access to the iFocus Measure platform.
• iFocus Platform The overarching ADHD treatment measurement system comprising webcam-based eye tracking, AI-powered data processing, and reporting. The platform integrates patient reading sessions, medication tracking, and clinician reporting into a unified workflow.

Quantifiable outcome

• Eye-tracking biomarker validated for ADHD treatment efficacy measurement
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• HarmonEyesflagshipStrategic or Co-development Partner · 1 September 2025iFocus technology was acquired by HarmonEyes, a leader in utilizing eye tracking and AI. HarmonEyes will develop the next version of the platform. This strategic acquisition is intended to bring iFocus technology to more people and continue the mission of objective ADHD treatment measurement.

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Cerebral: Large telehealth platform providing ADHD evaluation, medication management, and therapy. Overlaps with iFocus on the clinician-side ADHD treatment decision workflow and patient population, though Cerebral is a much broader mental-health service rather than a measurement tool.
• Headspace Health (Ginger): Large mental-health platform combining therapy, coaching, and self-guided content across ADHD, anxiety, and depression. Comparable patient population and digital-first delivery model, though at vastly greater scale and breadth.

Direct peers

• Akili Interactive: Digital therapeutics company that built FDA-cleared cognitive treatment products (EndeavorRx) for ADHD and other cognitive conditions. Directly comparable as a software-delivered, evidence-based behavioral/neurological intervention targeting the same ADHD patient population.
• Freespira: FDA-cleared digital therapeutic for panic disorder and PTSD using at-home biofeedback measurement. Comparable as a prescription digital therapeutic that produces objective measurement data to guide clinician treatment decisions.
• HarmonEyes: Eye-tracking and AI platform for healthcare applications that acquired iFocus Health's technology. Directly comparable as both leverage webcam/AI-based eye movement analysis for clinical decision support, and now operate as parent-subsidiary in ADHD measurement.
• Done (Done.): Telehealth platform focused specifically on ADHD diagnosis and ongoing treatment management. Comparable patient population and clinician-prescribing workflow, with potential to integrate objective measurement tools like iFocus.

Emerging players

• Mindstrong (defunct): Previously used smartphone interaction patterns and AI to derive objective biomarkers for mental health conditions including depression and schizophrenia. Highly comparable thesis (objective AI biomarkers for behavioral health), though Mindstrong wound down operations, illustrating category execution risk.
• Ellipsis Health: AI company using voice biomarkers to detect and monitor mental health conditions such as depression and anxiety. Comparable in using AI-driven passive sensing (here voice, similar to iFocus's eye-tracking) to derive objective behavioral-health metrics.
• Behavidence: Digital behavioral health analytics company that uses passive smartphone sensing and AI to detect and monitor mental health conditions including ADHD. Comparable in using AI to derive objective behavioral/mental-health biomarkers from consumer devices.
• Virtue Health (ADHD-focused digital tools): Digital health company building evidence-based digital tools for ADHD management. Comparable in pursuing clinically validated software solutions targeting the same ADHD patient and clinician base.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/iFocusADHD
• LinkedInlinkedin.com/company/ifocus-test

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iFocus Health